Science Explorer Interactive view Map
Company · Emeryville · United States

Eureka Therapeutics (United States)

eurekatherapeutics.comROR OpenAlex
Research works
46
◆ 2% vs 2013–17
Citations
1.3k
28.1 per fractional work
Top-10% rate
19.8%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: Eureka Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.70× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 15.09× its world share, 2 worksImmunology and Micro…Chemistry: 0.36× its world share, 0 worksChemistryEngineering: 0.28× its world share, 0 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMedicine: 3.12× its world share, 7 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.1×. Every wedge is a field page.

Who are the top researchers at Eureka Therapeutics (United States)?

Ranked on the composite score, Liu C lead among researchers whose main affiliation is Eureka Therapeutics (United States).

  1. 1 Liu C United States · #999,639 worldwide 77 citations · 101 works
All ranked researchers at Eureka Therapeutics (United States)

Which keywords describe research at Eureka Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Cancer Immunotherapy14▲ 214×3 topics
  2. Immunotherapy12▲ 41×7 topics
  3. Lymphoma11▲ 164×2 topics
  4. Tumor Regression11▲ 281×2 topics
  5. CAR T Cells11▲ 547×1 topic
  6. Chimeric Antigen Receptor11▲ 547×1 topic
  7. Glycosylation6▲ 58×3 topics
  8. Monoclonal Antibodies4▲ 69×3 topics
  9. Therapeutic Antibodies4▲ 69×2 topics
  10. Antibody Engineering4▲ 81×1 topic
  11. Fc Receptors4▲ 81×1 topic
  12. Immunity2▲ 16×3 topics
  13. Antigen Presentation2▲ 50×2 topics
  14. Innate Immunity2▲ 14×2 topics
  15. Dendritic Cells2▲ 42×1 topic
  16. Tumor Antigen2▲ 59×1 topic
  17. Cell Culture2▲ 41×2 topics
  18. Gene Therapy2▲ 17×4 topics
  19. Tumor Microenvironment2▲ 12×4 topics
  20. Cancer2▲ 2.9×11 topics
  21. Metabolism2▲ 6.2×5 topics
  22. Biopharmaceutical Production2▲ 46×2 topics
  23. Monoclonal Antibody2▲ 53×2 topics
  24. Inflammation2▲ 1.51×9 topics
  25. Mammalian Cells2▲ 91×1 topic
  26. Recombinant Protein2▲ 91×1 topic
  27. Nuclear Receptors2▲ 18×3 topics
  28. Kidney Organoids1▲ 88×1 topic
  29. Nephrogenesis1▲ 88×1 topic
  30. Prognostic Factors1▲ 6.5×5 topics
  31. AAV1▲ 40×1 topic
  32. Genomic Integration1▲ 25×2 topics
  33. Immune Checkpoint Blockade1▲ 49×1 topic
  34. PD-1 and PD-L11▲ 49×1 topic
  35. Viral Vectors1▲ 40×1 topic
  36. Autoimmunity1▲ 12×2 topics
  37. Macrophage1▲ 43×2 topics
  38. Collaborative Partnerships1▲ 105×1 topic
  39. Community Empowerment1▲ 6.8×1 topic

Which research topics does Eureka Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksImmunotherapy and Immune Responses: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksNeonatal Respiratory Health Research: 0 fractional worksNanopore and Nanochannel Transport Studies: 0 fractional worksGenomics and Rare Diseases: 0 fractional worksCancer Cells and Metastasis: 0 fractional worksCystic Fibrosis Research Advances: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingImmunologyMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 0 works
  6. 6 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
  7. 7 Nanopore and Nanochannel Transport Studies Biomedical Engineering 0 works
  8. 8 Genomics and Rare Diseases Genetics 0 works
  9. 9 Cancer Cells and Metastasis Oncology 0 works
  10. 10 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 28% of research is openly available.

with international co-authors21.9%domestic only78.1%

World: 19% is written across borders.

How has Eureka Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 2% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Emeryville

All research institutions in Emeryville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.